CINECA IRIS Institutional Research Information System

DA SETTIMO PASSETTI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.968
AS - Asia 13.928
EU - Europa 11.950
SA - Sud America 1.706
AF - Africa 592
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 4
Totale 55.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.106
IT - Italia 4.491
SG - Singapore 4.106
CN - Cina 3.766
HK - Hong Kong 1.977
SE - Svezia 1.939
VN - Vietnam 1.629
BR - Brasile 1.410
DE - Germania 1.282
BG - Bulgaria 844
TR - Turchia 714
CA - Canada 676
GB - Regno Unito 608
FR - Francia 554
FI - Finlandia 517
RU - Federazione Russa 450
IN - India 366
AT - Austria 349
UA - Ucraina 346
JP - Giappone 345
KR - Corea 266
CI - Costa d'Avorio 162
CH - Svizzera 134
BD - Bangladesh 118
IQ - Iraq 102
NG - Nigeria 102
MX - Messico 93
AR - Argentina 84
PK - Pakistan 84
ZA - Sudafrica 76
NL - Olanda 75
BE - Belgio 72
AU - Australia 71
PL - Polonia 71
SN - Senegal 68
ID - Indonesia 63
SA - Arabia Saudita 61
ES - Italia 58
UZ - Uzbekistan 50
EC - Ecuador 44
CO - Colombia 43
VE - Venezuela 41
EG - Egitto 37
KE - Kenya 33
JO - Giordania 32
MA - Marocco 30
MY - Malesia 30
CZ - Repubblica Ceca 25
PH - Filippine 24
JM - Giamaica 23
AZ - Azerbaigian 21
IE - Irlanda 21
PY - Paraguay 20
DZ - Algeria 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
GR - Grecia 18
LT - Lituania 18
CL - Cile 17
KZ - Kazakistan 16
TW - Taiwan 16
IR - Iran 14
UY - Uruguay 14
IL - Israele 13
OM - Oman 13
TT - Trinidad e Tobago 13
CR - Costa Rica 12
ET - Etiopia 12
LB - Libano 12
GE - Georgia 11
BJ - Benin 10
BO - Bolivia 10
DK - Danimarca 10
PA - Panama 9
PT - Portogallo 9
AL - Albania 8
HU - Ungheria 8
NP - Nepal 8
PS - Palestinian Territory 7
RO - Romania 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
NI - Nicaragua 6
BF - Burkina Faso 5
BH - Bahrain 5
EE - Estonia 5
LY - Libia 5
PR - Porto Rico 5
TH - Thailandia 5
BN - Brunei Darussalam 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
Totale 55.140
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.894
Ashburn 2.472
Ann Arbor 2.320
Singapore 2.279
Houston 2.071
Hong Kong 1.926
Serra 1.616
Chandler 1.591
Fairfield 1.559
San Jose 1.437
Santa Clara 1.313
Dallas 1.124
Sofia 842
Milan 769
Beijing 761
Shanghai 740
Seattle 628
Wilmington 624
New York 586
Ottawa 542
Izmir 499
Cambridge 476
Ho Chi Minh City 430
Los Angeles 425
Jacksonville 417
Boardman 412
Princeton 384
Hefei 349
Lawrence 334
Hanoi 321
Lauterbourg 312
Nanjing 296
Vienna 289
Medford 276
Tokyo 266
Seoul 253
Council Bluffs 250
Frankfurt am Main 227
Des Moines 216
Dong Ket 209
London 209
Rho 180
Helsinki 165
Abidjan 162
Istanbul 159
Dearborn 155
Pisa 138
Buffalo 133
Redondo Beach 131
Rome 120
São Paulo 116
Munich 104
Lagos 99
Florence 97
Nanchang 96
Chicago 95
Bern 94
Bremen 94
San Diego 91
Düsseldorf 82
The Dalles 81
Columbus 78
Redwood City 76
Da Nang 72
Brussels 71
Ogden 70
Boulder 69
Dakar 68
Jüchen 68
Pune 67
Shenyang 67
Kunming 65
Orem 62
Hebei 59
Turku 53
Warsaw 53
Falls Church 52
San Francisco 50
Changsha 49
Tashkent 48
Fuzhou 47
Haiphong 46
Nürnberg 46
Guangzhou 45
Lucca 45
Sydney 44
Belo Horizonte 43
Johannesburg 43
Rio de Janeiro 39
Tianjin 39
Toronto 39
Auburn Hills 36
Baghdad 35
Norwalk 35
Nuremberg 35
Paris 35
Washington 35
Dhaka 32
Livorno 32
Hangzhou 31
Totale 39.315
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 407
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 371
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 332
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 297
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 292
Soyasaponins from Zolfino bean as aldose reductase differential inhibitors 284
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 277
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 274
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 258
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 253
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 252
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 249
N '-phenylindol-3-ylglyoxylohydrazide derivatives: Synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors 248
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 242
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 240
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 236
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 232
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 230
Allosteric modulators of human A2B adenosine receptor. 230
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 230
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 228
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 228
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 227
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 227
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 226
Functional Studies in the Year of Pulses: the case of Zolfino landraces (Phaesolus vulgaris L.) 225
Metformin conjugates and therapeutic use thereof 224
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 222
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 220
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 216
The ra structure of tellurophene-2-carboxaldehyde by using the proton NMR spectrum in an oriented phase including carbon-13 and tellurium-125 satellites 214
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 214
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 214
An update into the medicinal chemistry of translocator protein (TSPO) ligands 213
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 212
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 212
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 209
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 209
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 208
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 207
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 206
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
1-Substituted 2-(benzylamino)benzimidazole derivatives: compounds with H1-antihistaminic activity 204
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 204
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 203
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 202
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 202
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 200
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 199
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 199
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 198
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 198
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 197
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 197
TSPO Radioligands for Neuroinflammation: An Overview 196
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 196
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 195
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 194
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 194
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 194
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 193
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 193
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 193
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 192
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 192
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 192
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 190
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 190
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 190
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 189
Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening 188
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 188
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 188
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 188
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 188
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 187
Synthesis of novel 1-aryl[1]benzoxepino[5,4-c]pyrazole and [1]benzoxepino[5,4-d]pyrimidine derivatives 187
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 187
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 187
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 187
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 185
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 184
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 183
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 183
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 183
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 182
Novel, Highly Potent Aldose Reductase Inhibitors:Cyano(2-oxo-2,3-dihydroindol-3-yl)acetic Acid Derivatives 181
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 181
A New Approach to Control the Enigmatic Activity of Aldose Reductase 180
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 179
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 179
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 178
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 178
Totale 21.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021633 0 0 0 0 0 0 0 0 0 0 156 477
2021/20224.047 100 333 155 250 673 552 120 203 144 131 234 1.152
2022/20235.403 675 817 372 540 602 693 60 397 907 30 245 65
2023/20243.696 424 364 419 224 495 722 190 108 64 92 186 408
2024/202511.047 73 407 114 690 1.195 1.074 822 539 1.030 1.422 1.162 2.519
2025/202612.247 657 1.538 1.418 940 1.217 1.110 2.675 610 815 1.107 160 0
Totale 55.995